Remote Theranostics Clinical Lead – Nuclear Medicine

Bristol-Myers Squibb Company; United States; Remote; USD 150,000 - 182,000; Full time

Benefits offered by this job

Flexible Time Off

11 paid company holidays

Paid vacation

Sick leave

Volunteer days

Summer hours

Leaves of absence

Global Shutdown

Job summary

RayzeBio, a Bristol Myers Squibb company, seeks a Senior Clinical Theranostics Specialist to advance radiopharmaceutical therapies in oncology. You will collaborate with physicians, trial teams, and researchers to optimize site readiness, educate staff, and ensure compliant, high-quality patient care.

Requirements include 5–7+ years in nuclear medicine or radiopharmaceuticals, strong cross-functional communication, and a proven track record leading education initiatives across clinical trials

Qualifications

• Bachelor’s degree required.
• 5–7+ years of experience in nuclear medicine, radiopharmaceutical clinical applications, oncology imaging, or related field.
• Demonstrated experience leading complex site education and workflow implementation initiatives.
• Advanced understanding of radiopharmaceutical science and diagnostic imaging trends.

Responsibilities

• Build and sustain strategic relationships with KOLs and institutional stakeholders.
• Lead site readiness and workflow integration for approved agents and trials.
• Deliver high-impact clinical and technical education for safe, effective product utilization.
• Serve as senior subject matter expert in nuclear medicine and radiopharmaceutical applications.

Skills

Nuclear medicine

Executive presence

Cross-functional collaboration

Education

Bachelor's degree

Job description

RayzeBio, a Bristol Myers Squibb company, seeks a Senior Clinical Theranostics Specialist to advance radiopharmaceutical therapies in oncology. You will collaborate with physicians, trial teams, and researchers to optimize site readiness, educate staff, and ensure compliant, high-quality patient care.

Requirements include 5–7+ years in nuclear medicine or radiopharmaceuticals, strong cross-functional communication, and a proven track record leading education initiatives across clinical trials